Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17616283 | APPLICATION OF ANTIARRHYTHMIC AGENTS TO STEM CELL DERIVED CARDIOMYOCYTES AND USES THEREOF | Final Rejection | Novo Nordisk A/S |
| 17842715 | CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS | Final Rejection | Genentech, Inc. |
| 17921739 | Methods for Generating Thymic Cells in Vitro | Final Rejection | The Regents of the University of California |
| 17768217 | TRANSPLANTED CELL PROTECTION VIA Fc SEQUESTRATION | Non-Final OA | The Regents of the University of California |
| 17262460 | Treatment of Vascular Occlusion by Activation of Notch Signaling | Non-Final OA | The Regents of the University of California |
| 17610124 | EXTRACELLULAR MATRIX MATERIAL AND USES THEREOF | Non-Final OA | The Chinese University of Hong Kong |
| 17048289 | INDUCTION OF MYELINATING OLIGODENDROCYTES IN HUMAN CORTICAL SPHEROIDS | Final Rejection | Case Western Reserve University |
| 19060439 | CULTURE MEDIA AND CONDITIONS FOR IN VITRO EXPANSION OF HEPATOCYTES | Final Rejection | Satellite Biosciences, Inc. |
| 17611241 | HIGH CONCENTRATION CELL PACKAGING AND SHIPPING | Final Rejection | Rutgers, The State University of New Jersey |
| 18633827 | METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17738843 | EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17921606 | METHODS FOR ISOLATING AND CULTURING TUMOR CELLS | Final Rejection | Georgetown University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy